This announcement is a separate document:
北京海润天睿律师事务所关于奥翔药业非公开发行股票发行过程和认购对象合规性之法律意见书
Legal opinion of Beijing Hairun Tianrui Law Firm on Aoxiang Pharmaceutical's non-public stock issuance process and subscription target compliance
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.